Insiders · Profile

Babu Yarlagadda S

Chief Discovery Officer at BIOCRYST PHARMACEUTICALS. Filing since 23 Sep 2009. CIK 0001452635

Company
Date
Role
Action
Shares
Amount
Of holding
14 Nov 2022
Chief Discovery Officer
Sold, plan not stated
31,515
$437.43K
9.5%
7 Mar 2022
Chief Discovery Officer
Sold, plan not stated
20,000
$343.20K
8.0%
7 Dec 2021
Chief Discovery Officer
Sold, plan not stated
30,100
$367.22K
12.3%
18 Nov 2019
Senior VP - Drug Discovery
Bought
25,000
$36.25K
19.1%
25 Aug 2016
Senior VP - Drug Discovery
Sold, plan not stated
30,000
$121.80K
21.2%
19 Mar 2015
Senior VP - Drug Discovery
Sold, plan not stated
12,105
$122.99K
7.5%
5 Mar 2015
Senior VP - Drug Discovery
Sold, plan not stated
37,400
$396.07K
18.9%
4 Mar 2015
Senior VP - Drug Discovery
Sold, plan not stated
10,495
$110.20K
5.0%
4 Mar 2014
Senior VP - Drug Discovery
Sold, plan not stated
40,642
$510.87K
16.3%
2 Mar 2012
VP Drug Discovery
Sold, plan not stated
837
$4.00K
0.7%
22 Feb 2012
VP Drug Discovery
Sold, plan not stated
30,912
$130.45K
37.0%
26 Oct 2009
VP Drug Discovery
Sold, plan not stated
6,400
$69.42K
14.0%
21 Oct 2009
VP Drug Discovery
Sold, plan not stated
200
$2.00K
0.4%
20 Oct 2009
VP Drug Discovery
Sold, plan not stated
3,400
$34.00K
6.9%
23 Sep 2009
VP Drug Discovery
Sold, plan not stated
20,000
$182.72K
28.8%
15 decisions on file.